Indevus/Pliva Trospium Co-Promotion Puts 481 Reps Behind Incontinence Drug
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Indevus’ co-promotion deal with Pliva will almost double the sales force for the U.S. launch of the overactive bladder treatment Sanctura (trospium).